- The FDA is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood-clotting disorder.
- The FDA said the recommendation is “out of an abundance of caution.”
- The cases occurred in women ages 18 to 48, with symptoms developing six to 13 days after they received the shot.
The Food and Drug Administration said Tuesday it is asking states to temporarily halt using Johnson & Johnson’s Covid-19 vaccine “out of an abundance of caution” after six women in the U.S. developed a rare blood clotting disorder.
“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”
Also in North Carolina and Colorado. Hard to know if there’s really much there or not. Stay tuned.